StockNews.AI
STSS
StockNews.AI
71 days

Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025

1. Sharps Technology's CEO will present at the Virtual Investor Summit on June 10. 2. The company commenced shipments, marking its shift to revenue-generating operations. 3. Shipments come from an upgraded facility in Hungary, supporting high-volume production. 4. The summit is focused on undervalued micro-cap stocks with significant growth potential. 5. Investors are invited to register for the webcast to gain insights.

7m saved
Insight
Article

FAQ

Why Bullish?

STSS is transitioning to revenue; successful execution may boost investor confidence. Previous similar scenarios in micro-cap companies often led to price increases post-revenue generation announcements.

How important is it?

Positive news about revenue generation and investor engagement increases STSS's market appeal and valuation potential.

Why Short Term?

The upcoming investor summit may lead to immediate interest and stock price movement. Timely updates can amplify investor sentiment.

Related Companies

HIIQMNRO
Presentation to be webcast live at 10:00 AM ET June 09, 2025 13:12 ET  | Source: Sharps Technology Inc NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: “STSS” and “STSSW”) (“Sharps”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart safety syringe products to the healthcare industry, today announced that Robert Hayes, CEO, will present at the Virtual Investor Summit on June 10, 2025, at 10:00 AM ET. Investors are invited to listen to the presentation and can register here. Sharps recently announced that the Company has commenced shipments under three customer orders tied to previously announced purchase agreements. These shipments represent the Company’s first commercial deliveries and its transition to revenue-generating operations. All products are being manufactured and shipped from Sharps’ facility in Hungary, which has undergone significant upgrades to support high-volume production. Read the update release HERE. Presentation Details: Event: Q2 Investor SummitDate & Time: 10:00 AM ET on June 10, 2025Presenter: Robert Hayes, CEOWebcast: LINK HERE Conference Overview and Structure:The Investor Summit is an exclusive event tailored for investors focused on small- and micro-cap stocks. It offers a unique opportunity to meet with management teams from high-potential emerging companies, gain insights from industry experts, and understand how peers are navigating the current market environment. This quarter’s event centers on micro-cap companies that are currently undervalued and positioned near catalyst events that could significantly accelerate their growth trajectory. Registration for Investors:To request free registration, please go to the Investor Summit website, (https://investorsummitgroup.com/), and click the "Registration" button. For More Information, please visit: https://investorsummitgroup.com/, or, contact johnna-mae@investorsummitgroup.com. About Sharps Technology:Sharps Technology is an innovative medical device and pharmaceutical packaging company offering patented, best-in-class smart-safety syringe products to the healthcare industry. The Company’s product lines focus on providing ultra-low waste capabilities, that incorporate syringe technologies that use both passive and active safety features. Sharps also offers products that are designed with specialized copolymer technology to support the prefillable syringe market segment. The Company has a manufacturing facility in Hungary. For additional information, please visit www.sharpstechnology.com. FORWARD-LOOKING STATEMENTS:This press release contains “forward-looking statements”. Forward-looking statements reflect our current view about future events. When used in this press release, the words “anticipate,” “believe,” “estimate,” “expect,” “future,” “intend,” “plan,” “poised” or the negative of these terms and similar expressions, as they relate to us or our management, identify forward-looking statements. Such statements, include, but are not limited to, statements contained in this press release relating to our business strategy, our future operating results and liquidity, and capital resources outlook. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy, and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. They are neither statements of historical fact nor guarantees of assurance of future performance. We caution you therefore against relying on any of these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, our ability to raise capital to fund continuing operations; our ability to protect our intellectual property rights; the impact of any infringement actions or other litigation brought against us; competition from other providers and products; our ability to develop and commercialize products and services; changes in government regulation; our ability to complete capital raising transactions; and other factors relating to our industry, our operations and results of operations. Actual results may differ significantly from those anticipated, believed, estimated, expected, intended, or planned. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We cannot guarantee future results, levels of activity, performance, or achievements. The Company assumes no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Investor Contact:Holdsworth PartnersAdam HoldsworthPhone: 917-497-9287Email: IR@sharpstechnology.com

Related News